Family · Pharmaceutical analytical standards
Indacaterol
A long-acting beta-2 agonist bronchodilator, approved in Europe in 2009 and in the United States in 2011 for maintenance treatment of chronic obstructive pulmonary disease (COPD). This family brings together the active ingredient, metabolites, labelled standards, nitrosamines and other impurities.
Did you know?It was the first long-acting beta-2 agonist approved for a single inhalation a day: its bronchodilator effect covers the full 24 hours.
No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
